Michael F. Maclean
Director · Camp4 Therapeutics Corp
- 2024
- Apr 3, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael F. Maclean files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VI, LLC - $4.86M in CAMP purchases and sales in the last 12 months
- Andrew J. Schwab - $2.50M in CAMP purchases and sales in the last 12 months
- Sarah Boyce - $1.04M in RNAM purchases and sales in the last 12 months
- W. Michael Flanagan - $473K in RNAM purchases and sales in the last 12 months
- Steven George Hughes - $460K in RNAM purchases and sales in the last 12 months
- Teresa McCarthy - $212K in RNAM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael F. Maclean?
Michael F. Maclean is a corporate insider, tracked as Director of Camp4 Therapeutics Corp (CAMP). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael F. Maclean last file a Form 4?
The most recent primary Form 4 on record is dated 3 April 2026, one of 7 filings going back to 2024.
Has Michael F. Maclean been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($6.86M) across all tracked filings.
